Lawsuits Over Viagra, Cialis Melanoma Risk Stayed 60 Days Following Exclusion of Plaintiffs’ Expert Witnesses
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Melanoma Risk with Viagra Seen in Study, But Causal Link Questioned June 24, 2015 Irvin Jackson Add Your Comments Amid continuing concerns that side effects of Viagra may increase the risk of skin cancer, new research seems to confirm an association between use of erectile dysfunction drugs and a diagnosis of melanoma. However, the researchers question whether Viagra or other similar medications may be the actual cause. In a study published this week in the Journal of the American Medical Association (JAMA), researchers found that Viagra and other drugs that are part of a class of medications known as phosphodiesterase type 5 (PDE5 ) inhibitors were linked to a 32% increased risk of melanoma among white males. Melanoma is a serious and potentially deadly form of skin cancer. Prior studies have identified a potential melanoma risk with Viagra, leading to a number of recent product liability lawsuits against Pfizer. Learn More About Viagra Melanoma Lawsuit Side Effects of Viagra Linked to Risk of Melanoma Skin Cancer Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Viagra Melanoma Lawsuit Side Effects of Viagra Linked to Risk of Melanoma Skin Cancer Learn More SEE IF YOU QUALIFY FOR COMPENSATION Despite the findings that users face an increased risk of being diagnosed with melanoma, researchers indicate that they found discrepancies in the numbers that suggest PDE5 inhibitors may not be the actual cause of these skin cancer cases. Instead, the increased risk may be a reflection of the lifestyle that men likely to use the drugs lead. Researchers looked at Swedish medical records from 2006 to 2012 and found about 4,000 cases where men were diagnosed with melanoma skin cancer. About 11% of those men had filled a prescription for at least one PDE5 inhibitor. According to the findings, men who filled just one prescription for the drugs were at 32% higher risk of melanoma than men who did not use the drugs. However, the number appeared to decline with use, with men who filled multiple prescriptions at only 14% higher risk. Researchers determined that there were seven additional cases of melanoma per 100,000 men taking Viagra or a similar drugs. “What our study results show is that groups of men who are more likely to get malignant melanoma include those with higher disposable incomes and education — men who likely can also afford more vacations in the sun — and who also have the means to buy erectile dysfunction medications, which are very expensive,” lead researcher, Dr. Stacy Loeb, a New York University Langone urologist, said in a university press release. Viagra (sildenafil citrate) was introduced by Pfizer in 1998, and it has become a blockbuster medication and one of the most widely known prescription medications in the country. The impotence drug has been aggressively promoted as a safe treatment for erectile dysfunction, which causes a number of men to experience sexual problems, including the inability to develop or maintain an erection. Viagra and Melanoma Concerns about the link between Viagra and melanoma surfaced early last year, when a study published by researchers from Harvard Medical School found that men who took Viagra were 84% more likely to be diagnosed with melanoma skin cancer than men who do not use the drug. The Harvard study and other research prior to that have noted that there is a likely mechanism of action that can explain the increased melanoma risk with Viagra and other erectile dysfunction drugs. Researchers have noted that PDE5A is a cancer-fighting protein, and that the erectile dysfunction drugs lower both PDE5 and PDE5A. This could cause a reduction in the ability of the body to fight or contain cancer, allowing malignant melanoma cells to spread more rapidly. As early as 2011, a study was published in the medical journal Cancer Cell which warned that Viagra could promote melanoma cell invasion. Another study published in the Journal of Cell Biochemistry in 2012 also found that PDE5 inhibitors like Viagra could exacerbate melanoma development. The American Cancer Society indicates that melanoma is diagnosed in about 69,000 Americans each year and causes about 8,650 deaths annually. The skin cancer usually manifests as unusual moles or patches of skin. While it is often curable if caught early, once melanoma has spread beyond the skin and local lymph nodes, treatment is difficult and it may ultimately result in death. Pfizer, the makers of Viagra, face a growing number of Viagra melanoma lawsuits by men who say they were diagnosed with melanoma after using the drug. The complaints allege that the drug maker aggressively marketed the erectile dysfunction drug without adequately researching the potential risk of melanoma or warning about the importance of monitoring for signs of skin cancer while taking the drug. Tags: Cancer, Cialis, Erectile Dysfunction, Levitra, Melanoma, Pfizer, Skin Cancer, Viagra More Viagra Lawsuit Stories Study Links Serious Vision, Retinal Problems to Viagra, Cialis Side Effects April 11, 2022 Lawsuits Over Viagra, Cialis Melanoma Risk Stayed 60 Days Following Exclusion of Plaintiffs’ Expert Witnesses February 5, 2020 Status of Viagra, Cialis Viagra Lawsuits to be Reviewed During Case Management Conference October 15, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Lawsuits Over Viagra, Cialis Melanoma Risk Stayed 60 Days Following Exclusion of Plaintiffs’ Expert Witnesses February 5, 2020
Status of Viagra, Cialis Viagra Lawsuits to be Reviewed During Case Management Conference October 15, 2018
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)